Security record · archived quarter
LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare · Biotechnology
13Tracked holders
0Δ holders
62.78MShares held
$84.76MReported value
+2New positions
−2Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +8.6% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +16 | 115.42M | $276.97M | +20 | −4 |
| Q1 2026 | 53 | +1 | 96.42M | $150.42M | +5 | −4 |
| Q4 2025 | 51 | +1 | 73.64M | $84.69M | +2 | −1 |
| Q3 2025 | 13 | 0 | 62.78M | $84.76M | +2 | −2 |
| Q2 2025 | 10 | +2 | 57.50M | $54.38M | +4 | −2 |
| Q1 2025 | 5 | -2 | 7.56M | $3.49M | +1 | −3 |
| Q4 2024 | 7 | -2 | 16.13M | $11.91M | +1 | −3 |
| Q3 2024 | 8 | 0 | 7.88M | $12.37M | — | — |
| Q2 2024 | 8 | — | 12.44M | $20.91M | — | — |
Who holds it · Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 38.68M | +1.4% | $52.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 38.68M | +1.4% | $52.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 38.68M | +1.4% | $52.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 9.52M | +7.6% | $12.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 9.52M | +7.6% | $12.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passive) | 9.52M | +7.6% | $12.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 3.83M | +133.1% | $5.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 3.39M | +1.2% | $4.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 3.39M | +1.2% | $4.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 3.39M | +1.2% | $4.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 2.63M | New | $3.56M | 0.0% | New | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 2.40M | +0.8% | $3.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 2.40M | +0.8% | $3.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passive) | 880.12K | +7.5% | $1.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 559.01K | +38.4% | $754,661 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 302.93K | -78.4% | $408,957 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 302.93K | -78.4% | $408,957 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 302.93K | -78.4% | $408,957 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 302.93K | -78.4% | $408,957 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 292.40K | New | $394,740 | 0.0% | New | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 169.02K | — | $228,175 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 169.02K | — | $228,175 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 169.02K | — | $228,175 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 169.02K | — | $228,175 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 169.02K | — | $228,175 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 60.07K | — | $81,100 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 60.07K | — | $81,100 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 59.35K | — | $80,118 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Goldman Sachs Group ✦ | 59.35K | — | $80,118 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $3.56M | 0.0% |
| Renaissance Technologies | $394,740 | 0.0% |
Exited
| Wellington Management | $460,248 | was 0.0% |
| D. E. Shaw & Co. | $22,435 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 136 holders, 323.38M shares, $502.11M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2025 ·
Methodology ·
Get this via the API